“This upcoming season, we look forward to Beyfortus offering its demonstrated real-world protection to as many infants as ...

French multinational pharmaceutical company Sanofi has commenced the shipping of BEYFORTUS (nirsevimab-alip) to the US, ...

With the peak flu season often occurring during December and January and even into February, Dr. Sharon Nachman, Chief of the ...

Generally, experts recommend COVID-19 and flu vaccines for most people and RSV vaccines for some. The vaccines are all safe ...

French pharma major Sanofi today revealed it is shipping Beyfortus (nirsevimab-alip) 50mg and 100mg Injection doses in the ...

Sanofi (SNYNF, SNY) said it is shipping BEYFORTUS 50mg and 100mg Injection doses in the US to private healthcare providers and to the ...

October: time for muddy soccer practices, cider pressing and Halloweentown ... And time to roll up your sleeves.

Company planning for every eligible baby in the US to have access to BEYFORTUS <li /> New BEYFORTUS filling line approved by the ...

The new, free vaccine, Beyfortus, will be available to children up to 24 months old through their health care provider or at ...

Analyst Graham Parry of Bank of America Securities maintained a Buy rating on Sanofi (SNYNF – Research Report), retaining the price ...

Infants born outside the RSV season can be vaccinated during regular check-ups, while those born during the season can access the vaccine at birth. BEYFORTUS stands out as the first and only long ...

Children don’t currently have an RSV vaccine option, but “vaccine-like” monoclonal antibody products—Beyfortus (nirsevimab) and Synagis (palivizumab)—can help protect infants and young ...